nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anasarca improved by extracorporeal ultrafiltration through an internal shunt in a case of severe haemophilia B with inhibitor and steroid-resistant nephrotic syndrome
|
SATOMURA, A. |
|
2006 |
12 |
1 |
p. 103-105 |
artikel |
2 |
A rapid multifluorescent polymerase chain reaction for genetic counselling in Chinese haemophilia A families
|
FANG, Y. |
|
2006 |
12 |
1 |
p. 62-67 |
artikel |
3 |
Canadian multi-institutional survey of immune tolerance therapy (ITT) – experience with the use of recombinant factor VIII for ITT
|
BARNES, C. |
|
2006 |
12 |
1 |
p. 1-6 |
artikel |
4 |
Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia
|
LINDVALL, K. |
|
2006 |
12 |
1 |
p. 47-51 |
artikel |
5 |
Congenital factor VII deficiency: therapy with recombinant activated factor VII – a critical appraisal
|
MARIANI, G. |
|
2006 |
12 |
1 |
p. 19-27 |
artikel |
6 |
Considerations in the evaluation of haemophilia patients for short-term prophylactic therapy: a paediatric and adult case study
|
LUCHTMAN-JONES, L. |
|
2006 |
12 |
1 |
p. 82-86 |
artikel |
7 |
Cost minimization model for treatment of minor bleeding episodes in inhibitor patients – methodological issues
|
SEREMETIS, S. |
|
2006 |
12 |
1 |
p. 108-109 |
artikel |
8 |
Deep vein thrombosis in a patient with severe haemophilia A
|
KASHYAP, R. |
|
2006 |
12 |
1 |
p. 87-89 |
artikel |
9 |
Haemophilia in Poland
|
WINDYGA, J. |
|
2006 |
12 |
1 |
p. 52-57 |
artikel |
10 |
Hepatitis C at the Israeli National Hemophilia Center
|
MAOR, Y. |
|
2006 |
12 |
1 |
p. 68-74 |
artikel |
11 |
Higher recovery of factor VIII (FVIII) with intermediate FVIII/von Willebrand factor concentrate than with recombinant FVIII in a haemophilia A patient with an inhibitor
|
INOUE, T. |
|
2006 |
12 |
1 |
p. 110-113 |
artikel |
12 |
Inhibitor challenges in the paediatric setting
|
SIEGER, L. |
|
2006 |
12 |
1 |
p. 106-107 |
artikel |
13 |
Long-term evaluation of radioisotope synovectomy with Yttrium 90 for chronic synovitis in Turkish haemophiliacs: Izmir experience
|
KAVAKLI, K. |
|
2006 |
12 |
1 |
p. 28-35 |
artikel |
14 |
Long-term prophylaxis with intermediate-purity factor VIII concentrate (Haemate P) in a patient with type 3 von Willebrand disease and recurrent gastrointestinal bleeding
|
COPPOLA, A. |
|
2006 |
12 |
1 |
p. 90-94 |
artikel |
15 |
Measuring patients’ perceptions on their functional abilities: validation of the Haemophilia Activities List
|
GENDEREN, F. R. |
|
2006 |
12 |
1 |
p. 36-46 |
artikel |
16 |
Needles and needleless devices for infusion of anti-haemophilic factor concentrate: impact on protein structure and function
|
PRABHU, S. |
|
2006 |
12 |
1 |
p. 58-61 |
artikel |
17 |
Practice patterns in haemophilia A therapy – global progress towards optimal care
|
GERAGHTY, S. |
|
2006 |
12 |
1 |
p. 75-81 |
artikel |
18 |
Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience
|
CARCAO, M. |
|
2006 |
12 |
1 |
p. 7-18 |
artikel |
19 |
Rituximab in the treatment of high responding inhibitors in severe haemophilia A
|
MOSCHOVI, M. |
|
2006 |
12 |
1 |
p. 95-99 |
artikel |
20 |
Successful induction of immune tolerance by continuous infusion of recombinant factor VIII in a haemophilia A patient with high-inhibitor titres
|
TAMURA, K. |
|
2006 |
12 |
1 |
p. 100-102 |
artikel |